Dexamethasone

Code: 265005-100MG D2-231

Biochem/physiol Actions

Cell permeable: no

Target IC50: 5 nM Inhibiting the expression of inducible but not constitutive nitric oxide synthase in vascular en...


read more

Your Price
€156.31 100MG
€192.26 inc. VAT

Biochem/physiol Actions

Cell permeable: no

Target IC50: 5 nM Inhibiting the expression of inducible but not constitutive nitric oxide synthase in vascular endothelial cells

Reversible: no

Primary TargetPhosphorylation of rb protein

Product does not compete with ATP.

General description

Most active and highly stable glucocorticoid. Inhibits the expression of inducible but not constitutive nitric oxide synthase in vascular endothelial cells (IC50 = 5 nM). Enhances active cation transport in aortic smooth muscle cells by stimulating the Na+-K+ pump. Has anti-inflammatory and antirheumatic properties. Induces apoptosis in human thymocytes. In general, 500-1000 nM of dexamethasone is sufficient to induce apoptosis following a 6 h incubation at 37°C.

Most active and highly stable glucocorticoid. Causes a reduction in cyclin A and Cdk2 activity, and inhibition of G1/S transition in osteoblasts. Inhibits the phosphorylation of retinoblastoma (Rb) protein. Inhibits the expression of inducible but not constitutive nitric oxide synthase in vascular endothelial cells (IC50 = 5 nM). Enhances active cation transport in aortic smooth muscle cells by stimulating the Na+ - K+ pump. Induces apoptosis in human thymocytes.

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Other Notes

Reil, T.D., et al. 2000. J. Surg. Res.92, 108.Smith, E., et al. 2000. J.Biol. Chem. 275, 1992.Petit, P.X., et al. 1995. J. Cell Biol.130, 157.Stern, N., et al. 1994. Am. J. Hypertens. 7, 146.Donis, J.A., et al. 1993. Biotechniques15, 786.Ohoka, Y., et al. 1993. Biochem. Biophys. Res. Commun.197, 916.Sarin, A., et al. 1993. J. Exp. Med.178, 1693.Vandewalle, A., et al. 1993. J. Cell Physiol.156, 383.Nieto, M.A., et al. 1992. Clin. Exp. Immunol.88, 341.Walsh, D., and Avashia, J. 1992. Cleveland Clin. J. Med. 59, 505.Warters, R.L. 1992. Cancer Res.52, 883.Sperber, K., et al. 1991. J. Allergy Clin. Immunol.87, 490.Radomski, M.W., et al. 1990. Proc. Natl. Acad. Sci. USA 87, 10043.Bettger, W.J., et al. 1981. Proc. Natl. Acad. Sci. USA78, 5588.

Packaging

100 mg in Plastic ampoule

Reconstitution

Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 2 months at -20°C.

Warning

Toxicity: Carcinogenic / Teratogenic (D)

assay≥99% (TLC)
colorwhite
formsolid
InChI keyUREBDLICKHMUKA-CXSFZGCWSA-N
InChI1S/C22H29FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12-,15+,16+,17+,19+,20+,21+,22+/m1/s1
manufacturer/tradenameCalbiochem®
Quality Level100
shipped inambient
solubilitychloroform: soluble, DMSO: 25 mg/mL, ethanol: soluble
storage conditionOK to freeze
storage temp.2-8°C
Cas Number50-02-2
This product has met the following criteria to qualify for the following awards:



PROCEED TO CHECKOUT

HAVE AN ACCOUNT? LOGIN


GUEST CHECKOUT

Proceed as a guest. You will have the option to register to access exclusive pricing and stock availability features after checkout.